Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
82 hedge funds and large institutions have $491M invested in Repare Therapeutics in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 5 closing their positions.
3,276% more call options, than puts
Call options by funds: $1.25M | Put options by funds: $37K
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
38% more capital invested
Capital invested by funds: $356M → $491M (+$135M)
24% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 21
15% more funds holding
Funds holding: 71 → 82 (+11)
1.43% more ownership
Funds ownership: 78.27% → 79.69% (+1.4%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.5M |
| 2 |
Millennium Management
New York
|
+$5.35M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$3.71M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$2.32M |
| 5 |
BlackRock
New York
|
+$713K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$5.98M |
| 2 |
CA
CHI Advisors
New York
|
-$4.03M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$3.05M |
| 4 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$2.08M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.81M |
RPTX Hedge Fund Activity: Q4 2022 in Review
82 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q4 2022, worth a combined $491M — up 38% from $356M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new RPTX positions and 5 closed out — a net gain of 11 holders — while 26 added to existing stakes and 21 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $10.5M. The largest seller was Deep Track Capital, cutting an estimated $5.98M.
- 82 institutional investors held Repare Therapeutics (RPTX) as of Q4 2022, up from 71 in Q3 2022.
- Funds reported $491M of Repare Therapeutics stock for Q4 2022, up 38% quarter-over-quarter.
- 16 funds opened new Repare Therapeutics positions in Q4 2022 and 5 closed out, a net change of +11 holders.
- The largest Repare Therapeutics buyer in Q4 2022 was Fidelity Investments, an estimated $10.5M added.
- The largest Repare Therapeutics seller in Q4 2022 was Deep Track Capital, an estimated $5.98M sold.
Based on aggregated 13F filings for Q4 2022.